查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363963

全球单采市场 2023-2030

Global Apheresis Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 105 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030 年），全球单采市场将以 8.4% 的复合年增长率成长。市场的成长归功于全球医疗技术的持续创新。 Spectra Optia 等单采系统提供了创新且有效的治疗替代方案，在全球范围内增加了使用量。在称为 RBCX 的治疗方法中，患者自身的红血球（通常是患病或有缺陷的细胞）被去除并用健康的供体红血球替代。除了治疗其他自体免疫疾病之外，镰状细胞性贫血和其他血红蛋白疾病等疾病的治疗通常还涉及外科手术。因此，市场参与者正在推出新产品来满足自动化红血球交换治疗的需求。例如，2022年6月，英国NHS英格兰选择在该公司的Spectra Optia血浆分离系统上进行自动红血球交换（RBCX）治疗来治疗镰状细胞疾病。这个选择导致 Spectra Optia 在英格兰各地的医院得到更广泛的部署。

细分市场前景

全球单采市场按产品、程序和应用进行细分。根据产品，市场分为单采一次性用品、单采设备、离心单采设备和薄膜分离设备。根据程序，市场分为自动血液采集、治疗性单采、治疗性单采一次性用品和治疗性单采设备。此外，根据应用，市场分为血浆去除术、血小板去除术、红血球去除术、白血球去除术和光去除术。在这些应用中，由于器官移植排斥治疗中对光去除术的需求不断增长以及血液疾病盛行率的增加，预计光球技术将占据相当大的市场份额。

预计血小板去除术细分市场将在全球单采术市场中占据相当大的份额

在这些应用中，血小板单采细分市场预计将在全球单采市场中占据相当大的份额。该细分市场的成长归因于全球慢性病盛行率的上升。多种慢性疾病的治疗，例如自体免疫疾病、神经系统问题和一些恶性肿瘤，有时涉及血浆分离术。随着疾病变得更加普遍，对单采手术的需求也越来越大。根据美国国立卫生研究院(NIH) 的数据，2022 年9 月，在接受血小板去除检查的7,478 名捐赠者中，有3,232 名(43.2%) 出现延误，其中3,089 名男性(42.5%) 名捐赠者和142 位(63.1%) 位女性捐赠者。 96.5% 的延期是暂时的。其中包括低血红素(Hb)（7.2%）和低静脉通路（分别为22.4% 和47.4%）。由于Hb 水平低而导致血红素下降的捐赠者中，有24.7%（234 名捐赠者中的58 名）的Hb 介于12.0%和12.4%。目前的捐赠者选择标准开放至最低血红蛋白12克/分升和最低血小板计数140 103/公升，有可能增加合格的血小板去除捐赠者的数量。

区域展望

全球单采市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国、亚太其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于人口密度高且老年人口增加，预计亚太地区将在全球市场中占据显着份额。

北美地区预计全球单采市场将以显着的复合年增长率成长

在所有地区中，北美地区预计在预测期内将以相当大的复合年增长率成长。除其他单采技术供应商外，自动采血和资讯系统製造商报告称，对其提供的产品和服务的需求不断增长。根据美国国立卫生研究院 (NIH) 的数据，2022 年 3 月，由于取消流动捐血活动，固定站点的单采程序总数增加了 37.0%，每张床位的轮次增加了 46.0%；然而，每个捐赠者获得的产品较少。只要取得所需数量，血小板过期率就从 6.8%（疫情前）降至 4.0% 以下。用于衡量捐血者参与度的捐血频率从 2020 年 1 月的 1.6 上升到 2021 年 3 月的 1.8。血液中心透过利用诸如自动化血液采集和资讯系统。

市场参与者展望

服务全球单采血液市场的主要公司包括 Cerus Corp.、Crown Bioscience, Inc.、Fresenius SE & Co. KGaA、Haemonetics、Kaneka Corp. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022 年 8 月，Terumo Blood and Cell Technologies 与 Eliaz Therapeutics Inc. (ETI) 合作，优化从血浆中选择性去除名为 Galectin-3 (Gal-3) 的上游发炎蛋白，以帮助治疗 AKI 和S -AKI。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球单采市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Asahi Kasei Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • B. Braun SE
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Baxter International, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按产品分類的全球单采市场
    • 单采一次性用品
    • 单采设备
  • 按程序分類的全球单采市场
    • 自动血液采集（供体血浆分离术）
    • 治疗性血浆分离术
  • 按应用分類的全球单采市场
    • 血浆分离术
    • 血小板去除术
    • 红血球去除手术
    • 白血球去除手术
    • 光采术

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Cerus Corp.
  • Crown Bioscience, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics
  • Kaneka Corp.
  • Macopharma
  • Nikkiso Co., Ltd.
  • Otsuka Holdings Co., Ltd.
  • SB-KAWASUMI LABORATORIES, INC.
  • Terumo BCT
  • Toray Medical Co., Ltd.
Product Code: OMR2027669

Title: Global Apheresis Market Size, Share & Trends Analysis Report by Product (Apheresis Disposables, Apheresis Devices), by Procedure (Automated blood collection, Therapeutic Apheresis), and by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis)Forecast Period (2023-2030).

The global apheresis market is anticipated to grow at a CAGR of 8.4% during the forecast period (2023-2030). The market's growth is attributed to the ongoing innovation in medical technology across the globe. Apheresis systems such as Spectra Optia provide innovative and effective treatment alternatives, increasing usage globally. In a therapeutic treatment known as RBCX, the patient's own red blood cells-often sick or defective cells-are removed and replaced with healthy donor red blood cells. Treatment for diseases like sickle cell anemia and other hemoglobinopathies, in addition to therapy for other autoimmune disorders, frequently involves surgical procedures. Accordingly, market players are coming up with new products to cater the demand for automated red blood cell exchange treatment. For instance, in June 2022, NHS England in the UK has chosen the automated red blood cell exchange (RBCX) treatment carried out on the company's Spectra Optia Apheresis System to treat sickle cell disease. This choice led to a wider deployment of Spectra Optia in hospitals throughout England.

Segmental Outlook

The global apheresis market is segmented on the product, procedure, and application. Based on the product, the market is sub-segmented into apheresis disposables, apheresis devices, centrifugal apheresis devices, and membrane separation devices. Based on the procedure, the market is sub-segmented into automated blood collection, therapeutic apheresis, therapeutic apheresis disposables, and therapeutic apheresis devices. Further, on the basis of application, the market is sub-segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and photopheresis. Among the application, the photospheres is sub-segment is anticipated to hold a considerable share of the market owing to the growing demand for photopheresis in organ transplant rejection therapies and increased prevalence of blood diseases.

The Plateletpheresis Sub-Segment is Anticipated to Hold a Considerable Share of the Global Apheresis Market

Among the application, the plateletpheresis sub-segment is expected to hold a considerable share of the global apheresis market. The segmental growth is attributed to the rising prevalence of chronic diseases around the globe. Treatment for a variety of chronic diseases, such as autoimmune disorders, neurological issues, and some malignancies, sometimes involves apheresis operations. Apheresis operations are in higher demand as the illnesses become more prevalent. According to the National Institute of Health (NIH), in September 2022, out of the 7,478 donors that were examined for plateletpheresis, 3,232 (43.2%) had delays, with 3,089 (42.5%) men and 142 (63.1%) women donors. 96.5% of extensions have been temporary. Low hemoglobin (Hb) (7.2%) and low venous access (22.4% and 47.4%, respectively, are among them. 24.7% (58 out of 234) of the donors that received a decline owing to the low Hb had a Hb between 12.0% and 12.4 %. The current donor selection criteria opened to a minimum Hb of 12 g/dl and minimum platelet count of 140 103/l, there is potential to increase the number of eligible plateletpheresis donors.

Regional Outlook

The global apheresis market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the high population density with an increase in senior citizen population.

The North America Region is Expected to Grow at a Significant CAGR in the Global Apheresis Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Manufacturers of automated blood collection and information systems in addition to other apheresis technology suppliers report growing demand for the products and services they supply. According to National Institute of Health (NIH), in March 2022, fixed sites increased total apheresis procedures by 37.0% and increased turns per bed by 46.0% as a result of the cancellation of mobile blood drives; however, less products were obtained per donor. Platelet expiration rate went from 6.8% (pre-pandemic) to less than 4.0% by simply obtaining the amount required. Donor frequency, that is used to measure donor involvement, went from 1.6 in January 2020 to 1.8 in March 2021. The blood center increased donor involvement and avoided accumulating an excess of simply specific kind of blood product throughout the epidemic by utilizing technology advancements such as automated blood collection and information systems.

Market Players Outlook

The major companies serving the global apheresis market include Cerus Corp., Crown Bioscience, Inc., Fresenius SE & Co. KGaA, Haemonetics, Kaneka Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022, Terumo Blood and Cell Technologies, and Eliaz Therapeutics Inc. (ETI), collaborated to optimize the selective removal of an upstream inflammatory protein termed Galectin-3 (Gal-3) from blood plasma to help treat AKI and S-AKI.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global apheresis market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Asahi Kasei Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. B. Braun SE
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Baxter International, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Apheresis Market by Product
    • 4.1.1. Apheresis Disposables
    • 4.1.2. Apheresis Devices
  • 4.2. Global Apheresis Market by Procedure
    • 4.2.1. Automated Blood Collection (Donor Apheresis)
    • 4.2.2. Therapeutic Apheresis
  • 4.3. Global Apheresis Market by Application
    • 4.3.1. Plasmapheresis
    • 4.3.2. Plateletpheresis
    • 4.3.3. Erythrocytapheresis
    • 4.3.4. Leukapheresis
    • 4.3.5. Photopheresis

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Cerus Corp.
  • 6.2. Crown Bioscience, Inc.
  • 6.3. Fresenius SE & Co. KGaA
  • 6.4. Haemonetics
  • 6.5. Kaneka Corp.
  • 6.6. Macopharma
  • 6.7. Nikkiso Co., Ltd.
  • 6.8. Otsuka Holdings Co., Ltd.
  • 6.9. SB-KAWASUMI LABORATORIES, INC.
  • 6.10. Terumo BCT
  • 6.11. Toray Medical Co., Ltd.

LIST OF TABLES

  • 1. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BYPRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL APHERESIS DISPOSABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL APHERESIS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL APHERESIS CENTRIFUGAL DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL MEMBRANE SEPARATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 7. GLOBAL APHERESIS BASED ON AUTOMATED BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL APHERESIS BASED ON THERAPEUTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL APHERESIS IN PLASMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL APHERESIS IN PLATELETPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL APHERESIS IN ERYTHROCYTAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL APHERESIS IN LEUKAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL APHERESIS IN PHOTOPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 22. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL APHERESIS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL APHERESIS DISPOSABLES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL APHERESIS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL APHERESIS CENTRIFUGAL DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL APHERESIS MEMBRANE SEPARATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL APHERESIS MARKET SHARE BY PROCEDURE, 2022 VS 2030 (%)
  • 7. GLOBAL APHERESIS BASED ON AUTOMATED BLOOD COLLECTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL APHERESIS BASED ON THERAPEUTIC APHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL APHERESIS MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL APHERESIS IN PLASMAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL APHERESIS IN PLATELETPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL APHERESIS IN ERYTHROCYTAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL APHERESIS IN LEUKAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL APHERESIS IN PHOTOPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL APHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. US APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF EUROPE APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SOUTH KOREA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)